TPPP/p25alpha Protein

Migration, Crosslink

📖

TPPP/p25alpha Protein

active

wiki page Created: 2026-04-02T07:19:13 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-tppp-protein

📖 Wiki Page

protein926 wordssynced 2026-04-02

TPPP/p25alpha Protein

Overview

TPPP/p25alpha (Tubulin Polymerization-Promoting Protein) is a 219 amino acid intrinsically disordered protein that stabilizes microtubules and promotes tubulin acetylation in [oligodendrocytes](/cell-types/oligodendrocytes). TPPP is the defining co-pathological marker of [multiple system atrophy](/diseases/multiple-system-atrophy) (MSA), where it co-aggregates with [alpha-synuclein](/proteins/alpha-synuclein) in glial cytoplasmic inclusions (GCIs). TPPP directly promotes alpha-synuclein aggregation into MSA-specific amyloid strains, distinguishing MSA pathology from [Parkinson's disease](/diseases/parkinsons-disease) Lewy bodies.

...

TPPP/p25alpha Protein

Overview

TPPP/p25alpha (Tubulin Polymerization-Promoting Protein) is a 219 amino acid intrinsically disordered protein that stabilizes microtubules and promotes tubulin acetylation in [oligodendrocytes](/cell-types/oligodendrocytes). TPPP is the defining co-pathological marker of [multiple system atrophy](/diseases/multiple-system-atrophy) (MSA), where it co-aggregates with [alpha-synuclein](/proteins/alpha-synuclein) in glial cytoplasmic inclusions (GCIs). TPPP directly promotes alpha-synuclein aggregation into MSA-specific amyloid strains, distinguishing MSA pathology from [Parkinson's disease](/diseases/parkinsons-disease) Lewy bodies.

<div class="infobox infobox-protein"> [@lindersson2005]
<div class="infobox-header">TPPP/p25alpha Protein</div> [@toksi2010]
<table> [@peng2018]
<tr><td class="infobox-label">Protein Name</td><td>Tubulin Polymerization-Promoting Protein (p25alpha)</td></tr> [@mavroeidi2019]
<tr><td class="infobox-label">Gene</td><td>[TPPP](/genes/tppp)</td></tr> [@kovacs2004]
<tr><td class="infobox-label">UniProt ID</td><td>[O94811](https://www.uniprot.org/uniprot/O94811)</td></tr> [@hasegawa2010]
<tr><td class="infobox-label">Molecular Weight</td><td>~24 kDa</td></tr> [@schweighauser2020]
<tr><td class="infobox-label">Subcellular Localization</td><td>Cytoplasm (perinuclear, cell processes in oligodendrocytes)</td></tr>
<tr><td class="infobox-label">Protein Family</td><td>TPPP family (TPPP1/2/3)</td></tr>
<tr><td class="infobox-label">Associated Diseases</td><td>[Multiple System Atrophy](/diseases/multiple-system-atrophy), [Parkinson's disease](/diseases/parkinsons-disease)</td></tr>
</table>
</div>

Structure

TPPP is an intrinsically disordered protein (IDP) with no stable tertiary structure in solution:

Structural Features

N-terminal region (aa 1–43): Positively charged, unstructured. Contains the major tubulin-binding determinant
CORE/Rossmann-fold-like domain (aa 44–168): Despite being largely disordered, this region has a predicted nucleotide-binding fold resembling a Rossmann fold, responsible for GTPase activity. Contains Walker A and Walker B motifs
C-terminal region (aa 169–219): Negatively charged, highly flexible. Contributes to microtubule bundling activity
GTPase active site: The Walker A motif (GxxxxGK) and Walker B motif (DxxG) enable GTP hydrolysis with Km ~ 30 μM, similar to small GTPases

Disordered Nature

TPPP's intrinsic disorder is functionally important:

Enables promiscuous binding to multiple partners (tubulin, alpha-synuclein, HDAC6)
Allows conformational adaptation upon binding
Facilitates liquid-liquid phase separation and pathological aggregation
Circular dichroism shows predominantly random coil structure at physiological conditions
Upon binding tubulin, TPPP undergoes partial folding into alpha-helical segments

TPPP Family

The TPPP family has three members:

TPPP/p25alpha (this protein): Brain-specific, oligodendrocyte marker
TPPP2: Testis-specific
TPPP3/p20: Broader tissue expression, ciliary function

Normal Function

Microtubule Stabilization

TPPP is the only mammalian protein known to directly promote tubulin polymerization at substoichiometric concentrations:

Binds tubulin dimers with Kd ~ 2 μM and stabilized microtubules with higher affinity
Induces microtubule bundling by cross-linking adjacent polymers
Enhances cold-stable microtubule formation
Cooperates with [MAP2](/genes/map2) and [tau](/proteins/tau) for synergistic microtubule stabilization

HDAC6 Inhibition

TPPP directly binds and inhibits [HDAC6](/genes/hdac6), the major cytoplasmic tubulin deacetylase:

Promotes acetylated alpha-tubulin accumulation
Tubulin acetylation marks stable, long-lived microtubules
This function is critical for maintaining myelin sheath integrity in oligodendrocytes
TPPP-mediated tubulin acetylation also protects microtubules from severing by katanin

Oligodendrocyte Biology

TPPP is essential for:

Process extension during oligodendrocyte maturation
Myelin sheath wrapping and maintenance
Intracellular transport of myelin basic protein ([MBP](/genes/mbp)) and other myelin components
TPPP knockout mice show delayed myelination and subtle motor deficits

Role in Disease

Multiple System Atrophy

TPPP is central to MSA pathogenesis:

Glial Cytoplasmic Inclusions (GCIs):

TPPP co-localizes with alpha-synuclein in virtually all GCIs
TPPP immunoreactivity is more sensitive than alpha-synuclein for GCI detection
TPPP relocation from perinuclear cytoplasm to inclusions depletes it from microtubules

Seeding Mechanism:

TPPP directly binds alpha-synuclein through fuzzy interactions between their disordered regions
TPPP promotes alpha-synuclein oligomerization and fibrillization in vitro
The TPPP-alpha-synuclein complex generates a distinct amyloid strain compared to pure alpha-synuclein fibrils
Cryo-EM structures of MSA-derived alpha-synuclein fibrils reveal a unique fold different from PD/DLB Lewy body fibrils, potentially templated by TPPP interaction

Temporal Sequence:

Evidence suggests TPPP accumulation precedes alpha-synuclein aggregation in oligodendrocytes
TPPP may create the initial pathological seed that captures alpha-synuclein
Oligodendrocytes normally express very little alpha-synuclein, so its accumulation in GCIs likely requires uptake from the extracellular space, facilitated by TPPP-mediated templating

Demyelination:

TPPP sequestration into GCIs depletes it from microtubules, causing secondary demyelination
White matter degeneration in MSA correlates with GCI density and TPPP loss from functional pools

Parkinson's Disease

TPPP is NOT a major Lewy body component, making it a key differentiating marker between MSA and PD. However, experimental overexpression of TPPP in [neurons](/entities/neurons) promotes alpha-synuclein aggregation into Lewy body-like inclusions.

Biomarker Applications

CSF TPPP levels may distinguish MSA from PD (elevated in MSA due to oligodendrocyte damage)
Serum exosomal TPPP is under investigation as a blood-based MSA biomarker
TPPP immunohistochemistry is used neuropathologically to confirm MSA diagnosis

Therapeutic Targeting

Disrupting TPPP-Alpha-Synuclein Interaction

Peptide inhibitors targeting the binding interface
Small molecules identified by high-throughput screening
Challenge: both proteins are intrinsically disordered, making the interaction surface dynamic

HDAC6 Inhibitors

Compensate for TPPP loss from microtubules by pharmacologically inhibiting HDAC6, restoring tubulin acetylation in MSA oligodendrocytes.

Antisense Oligonucleotides

Reducing TPPP expression to prevent GCI seeding, balanced against myelin maintenance requirements.

External Links

[UniProt: O94811](https://www.uniprot.org/uniprot/O94811)
[GeneCards: TPPP](https://www.genecards.org/cgi-bin/carddisp.pl?gene=TPPP)

References

[Hlavanda et al., Brain-specific p25 protein binds to tubulin and microtubules and induces aberrant microtubule assemblies (2002) (2002)](https://doi.org/10.1021/bi020087a)

[Lindersson et al., p25alpha stimulates alpha-synuclein aggregation and is co-localized in alpha-synucleinopathies (2005) (2005)](https://doi.org/10.1074/jbc.M410409200)

[Tokési et al., TPPP/p25 promotes tubulin acetylation by inhibiting histone deacetylase 6 (2010) (2010)](https://doi.org/10.1074/jbc.M109.096578)

[Peng et al., Cellular milieu imparts distinct pathological alpha-synuclein strains (2018) (2018)](https://doi.org/10.1038/s41586-018-0104-4)

[Mavroeidi et al., Endogenous oligodendroglial alpha-synuclein and TPPP/p25alpha orchestrate alpha-synuclein pathology in MSA models (2019) (2019)](https://doi.org/10.1007/s00401-019-02014-y)

[Kovacs et al., Natively unfolded TPPP/p25 is a common marker of alpha-synucleinopathies (2004) (2004)](https://doi.org/10.1016/j.nbd.2004.06.006)

[Hasegawa et al., Role of TPPP/p25 in alpha-synuclein pathology of MSA (2010) (2010)](https://doi.org/10.1111/j.1440-1789.2009.01063.x)

[Schweighauser et al., Structures of alpha-synuclein filaments from multiple system atrophy (2020) (2020)](https://doi.org/10.1038/s41586-020-2317-6)

📖 View canonical wiki page →

Related Entities

TPPPPROTEIN

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-tppp-protein
kg_node_id	TPPPPROTEIN
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-93b4871619a8
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-tppp-protein'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

45%

Debates

0

Incoming

9

Outgoing

12

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

TPPP/p25alpha Protein

TPPP/p25alpha Protein

Overview

TPPP/p25alpha Protein

Overview

Structure

Structural Features

Disordered Nature

TPPP Family

Normal Function

Microtubule Stabilization

HDAC6 Inhibition

Oligodendrocyte Biology

Role in Disease

Multiple System Atrophy

Parkinson's Disease

Biomarker Applications

Therapeutic Targeting

Disrupting TPPP-Alpha-Synuclein Interaction

HDAC6 Inhibitors

Antisense Oligonucleotides

See Also

External Links

References

💬 Discussion